BioNxt provides development and IP update across sublingual pipeline
BioNxt (BNXTF) issues a development, intellectual property, and commercial update across its sublingual drug delivery pipeline.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.